Forte Biosciences Inc. buy krebskrebs
Start price
04.10.21
/
50%
€2.60
Target price
04.10.22
€5.00
Performance (%)
-58.69%
End price
05.10.22
€1.07
Summary
This prediction ended on 05.10.22 with a price of €1.07. The BUY prediction by krebskrebs for Forte Biosciences Inc. performed very badly with a performance of -58.69%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Forte Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by krebskrebs for this prediction
In the thread Tocagen diskutieren
In the thread Trading Tocagen
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten